Hiroki Ide
Impact in
Papers in
- Surgery 62
- Bladder and Urothelial Cancer Treatments 61
-
- Prostate Cancer Treatment and Research 13
- Prostate Cancer Diagnosis and Treatment 3
- Co-authors
- Hiroshi Miyamoto (36 shared papers)Satoshi Inoue (29 shared papers)Eiji Kashiwagi (20 shared papers)Takashi Kawahara (18 shared papers)Eiji Kikuchi (30 shared papers)Mototsugu Oya (29 shared papers)Yichun Zheng (12 shared papers)Taichi Mizushima (23 shared papers)
- Journals
- Japanese Journal of Clinical Oncology (8 papers)The Journal of Urology (7 papers)Annals of Surgical Oncology (5 papers)Urologic Oncology Seminars and Original Investigations (5 papers)British Journal of Cancer (4 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hiroki Ide
78 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 73
- Surgery 988
- Oncology 263
- Pulmonary and Respiratory Medicine 266
- Cancer Research 99
- Urology 51
Countries citing papers authored by Hiroki Ide
This map shows the geographic impact of Hiroki Ide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Ide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Ide more than expected).
Fields of papers citing papers by Hiroki Ide
This network shows the impact of papers produced by Hiroki Ide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Ide. The network helps show where Hiroki Ide may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroki Ide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 79 | |
| 2 | 2012 | 64 | |
| 3 | 2015 | 60 | |
| 4 | 2014 | 59 | |
| 5 | 2016 | 59 | |
| 6 | 2017 | 58 | |
| 7 | 2013 | 52 | |
| 8 | 2012 | 49 | |
| 9 | 2016 | 45 | |
| 10 | 2017 | 43 | |
| 11 | 2018 | 42 | |
| 12 | 2013 | 41 | |
| 13 | 2015 | 41 | |
| 14 | 2016 | 41 | |
| 15 | 2017 | 39 | |
| 16 | 2013 | 36 | |
| 17 | Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation. | 2015 | 34 |
| 18 | 2008 | 33 | |
| 19 | 2020 | 31 | |
| 20 | 2012 | 30 |
About Hiroki Ide
Hiroki Ide is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Genetics and Molecular Biology, having authored 80 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (61 papers), Prostate Cancer Treatment and Research (13 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Estrogen and related hormone effects (4 papers), FOXO transcription factor regulation (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Signaling Pathways in Disease (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Surgery (988 citations), Oncology (263 citations), Pulmonary and Respiratory Medicine (266 citations), Cancer Research (99 citations) and Urology (51 citations). Hiroki Ide has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hiroshi Miyamoto, Satoshi Inoue, Eiji Kashiwagi, Takashi Kawahara, Eiji Kikuchi, Mototsugu Oya, Yichun Zheng, Taichi Mizushima, George Jabboure Netto and Akira Miyajima. Their work appears in journals such as Japanese Journal of Clinical Oncology, The Journal of Urology, Annals of Surgical Oncology, Urologic Oncology Seminars and Original Investigations and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.